Narcotics Analgesics Market –
Drivers
Increase in the research for
narcotics analgesics drugs is projected to rise the growth of global Narcotics
Analgesics Market during the forecasted period. For instance, a phase III
clinical study by Loma Linda University is undergoing for drug Narco. The
objective of the study is to evaluate patient pain level in the immediate
post-operative period and quantify pain medication usage in patients who
undergo outpatient Ear, Nose, and Throat (ENT) surgeries. The study was started
in February 2018, and is estimated to complete in January 2019.
Furthermore, Temple University
along with AstraZeneca is undergoing clinical phase II study to assess the
effect of opioids on esophageal motility. The study found that chronic opioid
users are suffering with esophageal motor dysfunctioning. This study will
explore the safety and tolerability of MOVANTIK (Naloxegol) and is expected to
improve opioid- induced esophageal motility disorders. The study was started in
January 2017 and is expected to complete in January 2020.
Narcotics analgesics also
identified as opioids are the medications that imitate the activity of
endorphins, elements produced by the body to regulate pain. Opioids are used to
treat acute pain associated with surgery and other medical procedures, as well
as for persistent (chronic) and advance pain. They are also used to induce
anesthesia, cough syrups, and to suppress diarrhea. These drugs are offered via
prescription only. Since opioids are addictive and may result in fatal
overdose, thus sue of narcotics analgesics is strictly regulated by the
governments.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2308
Narcotics Analgesics Market –
Restraint
Shortages of narcotics analgesics
medications is likely to alter the growth of narcotics analgesics market. For
instance, according to the Drug Enforcement Administration (DEA) of U.S.
February 2018, hospitals and other healthcare providers in U.S. are currently
facing critical shortages of a number of injectable opioid medications,
including morphine, hydromorphone, and fentanyl. Injectable opioids are
critical to treating the pain needs of patients undergoing interventional
procedures such as cardiac catheterization and surgeries. Diminished supply of
these critical drugs, can lead to less efficient pain control for patients
since opioid analgesics are highly potent in pain control.
Narcotics Analgesics Market –
Regional Analysis
On the basis of region, the
global narcotics analgesics market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America is
likely to lead in the global narcotics analgesics market owing to rising misuse
of opioid analgesics. For instance, according to the Federal Government of
U.S., in 2015, 8.5 million people i.e. 3% of the population of U.S. misused
opioid painkillers in 2015, and 2.5 million were addicted to either painkillers
or heroin in 2015. Moreover, More than 33,000 people died from overdoses of
opioid drugs in 2015.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/narcotics-analgesics-market-2308
Europe region is also expected to
perceive extensive growth in global narcotics analgesics market since few
countries in the European Union are misusing prescription opioid analgesics as
normal pain killers which is not advisable since these are habit forming drugs.
For instance, according to BMC Psychiatry journal August 2016, Spain had the
highest use of opioids for non-medical purposes, and Great Britain had the
second-highest opioid users.
The key players operating in
narcotics analgesics market include, Pfizer Inc., Teva Pharmaceuticals,
Allergan plc, BioDelivery Sciences International, Inc., Endo Pharmaceuticals,
Inc., Akron, Inc., UCB, Inc., Endo Pharmaceuticals Inc., Sun Pharmaceutical
Industries Ltd., Boehringer Ingelheim GmbH, and Janssen Pharmaceuticals, Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2308
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment